A 16-year retrospective evaluation of opportunistic lung cancer screening with Low-Dose CT in China: comparative findings between never smokers and smokers

Author:

Tang Yanyan1,Zhao Shijun1,Zhou Lina1,Huang Yao1,Wang Jianwei1,Liang Min2,Wang Fei1,Zhu Haohua1,Qi Linlin1,Zhang Li1,Liu Li1,Hou Donghui1,Xu Zhijian1,Zhang Kai1,Tang Wei1,Wu Ning1

Affiliation:

1. National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College

2. Capital Medical University

Abstract

Abstract

Background Although low-dose computed tomography (LDCT) screening effectively reduces LC mortality in high-risk individuals with a history of smoking in China, the feasibility and efficacy of lung cancer screening (LCS) in never-smokers versus smokers remains unclear. Methods We conducted a retrospectively opportunistic analysis at the National Cancer Center (NCC) in China from January 2006 to December 2022. A comprehensive LCS initiative was undertaken, involving 30,468 participants (54.5% male). Participants underwent LCS using LDCT. Potential malignancies were managed through joint consensus between patients and their physicians. Epidemiology, screening eligibility criteria, and LC detection rates and survival outcomes were compared between smokers and never-smokers. Results Among 30,468 participants, 339 LCs were pathologically confirmed in 289 patients. The LC detection rate was 0.9% overall, 0.8% in smokers (71/9,042), and 1.0% in never-smokers (218/21,426). In smokers, LC detection rates were 0.5% and 1.1% in the < 20 and ≥ 20 pack-year subgroups, respectively (P = 0.001). Early-stage LC (stage 0 or I) was detected in 73.8% of smokers and 78.8% of never-smokers, while advanced LC (stage III–IV) was found in 8.8% and 4.2%, respectively. Significant differences in histologic types were found between smokers and never-smokers (P = 0.01), although adenocarcinoma was the most prevalent in both groups, at 83.0% and 78.8%, respectively. The median nodule size was 9.9 mm (8.0–13.8) in smokers and 9.2 mm (6.8–13.6) in never-smokers (P = 0.228). Never-smokers tended to favour surgical treatment alone (88.0%) more than smokers (81.3%). The 10-year survival rate was higher in never-smokers (92.6%) than in smokers (88.8%). Only 15.6% of patients with LC met the United States Preventive Services Task Force (USPSTF) criteria for LDCT eligibility, while 29.1% met the China guideline for the screening and early detection of lung cancer (CGSL) criteria. Conclusions LDCT screening improves early LC detection and treatment outcomes for both smokers and never-smokers. Significant differences exist in epidemiology, histologic type, and survival between these groups. USPSTF and CGSL criteria overlook a significant number of LC cases, underscoring the need to relax smoking criteria and include never-smokers into the Chinese LCS programme.

Publisher

Springer Science and Business Media LLC

Reference27 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA Cancer J Clin,2021

2. [Cancer incidence and mortality in China, 2022];Zheng RS;Zhonghua zhong liu za zhi [Chinese journal of oncology],2024

3. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle DR;N Engl J Med,2011

4. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial;Koning HJ;N Engl J Med,2020

5. Screening for Lung Cancer in Individuals Who Never Smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report;Kerpel-Fronius A;J Thorac oncology: official publication Int Association Study Lung Cancer,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3